Janus Henderson Group plc (JHG) 13D/13G Filings for Ascendis Pharma A/S (ASND)

Janus Henderson Group plc 13D and 13G filings for Ascendis Pharma A/S:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
2:57 pm
Purchase
2024-09-3013GAscendis Pharma A/S
ASND
JANUS HENDERSON GROUP PLC
JHG
4,186,694
7.000%
191,909increase
(+4.80%)
Filing
2024-02-13
11:57 am
Purchase
2023-12-3113GAscendis Pharma A/S
ASND
JANUS HENDERSON GROUP PLC
JHG
3,994,785
6.900%
350,830increase
(+9.63%)
Filing
2023-02-10
10:01 am
Purchase
2022-12-3113GAscendis Pharma A/S
ASND
JANUS HENDERSON GROUP PLC
JHG
3,643,955
6.400%
423,990increase
(+13.17%)
Filing
2022-02-10
2:12 pm
Purchase
2021-12-3113GAscendis Pharma A/S
ASND
JANUS HENDERSON GROUP PLC
JHG
3,219,965
5.700%
211,136increase
(+7.02%)
Filing
2021-02-12
3:00 pm
Purchase
2020-12-3113GAscendis Pharma A/S
ASND
JANUS HENDERSON GROUP PLC
JHG
3,008,829
5.600%
3,008,829increase
(New Position)
Filing